Barclays Maintains an 'Overweight' on CVS Caremark (CVS); Positive on Shares After Mee ing
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $94.01 -3.24%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Barclays maintains an 'Overweight' on CVS Caremark (NYSE: CVS) price target of $50.00.
Analyst, Meredith Adler, said, "Earlier this week we hosted CVS' CFO, Dave Denton and its SVP of Investor Relations, Nancy Christal, in meetings with European investors. Management re-iterated previous guidance that the dispute between Walgreen and Express Scripts would benefit 2Q results by $0.03-$0.04 but that 2H12 guidance includes no benefit, even though they seemed confident that much of the new business would be retained even if the dispute was resolved."
Alder sees CVS making progress on several fronts, and believes in the company's manangement, but she feels the current share price isn't reflecting the positive outlook.
For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.
Shares of CVS Caremark closed at $45.17 yesterday.
Analyst, Meredith Adler, said, "Earlier this week we hosted CVS' CFO, Dave Denton and its SVP of Investor Relations, Nancy Christal, in meetings with European investors. Management re-iterated previous guidance that the dispute between Walgreen and Express Scripts would benefit 2Q results by $0.03-$0.04 but that 2H12 guidance includes no benefit, even though they seemed confident that much of the new business would be retained even if the dispute was resolved."
Alder sees CVS making progress on several fronts, and believes in the company's manangement, but she feels the current share price isn't reflecting the positive outlook.
For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.
Shares of CVS Caremark closed at $45.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CVS Health names JPMorgan executive to board, Robbins exits
- Deutsche Bank Downgrades SentinelOne Inc (S) to Hold on Valuation
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
Create E-mail Alert Related Categories
Analyst Comments, Mergers and AcquisitionsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
